Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL3 | Q96JM7 | 14/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 11/20 | 0.61 |
| ▸ | MBTD1 | Q05BQ5 | 5/20 | 0.59 |
| ▸ | TP53BP1 | Q12888 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 2/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | HTR7 | P34969 | 1/20 | 0.50 |
| ▸ | HTR6 | P50406 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22941361 | 0.86 | L3MBTL3 (0.73) | L3MBTL3L3MBTL1MBTD1TP53BP1KDM4E | |
| SCHEMBL2741683 | 0.85 | HRH3 (0.62) | L3MBTL3L3MBTL1MBTD1HTR2AHTR2C | |
| SCHEMBL7031548 | 0.85 | HRH3 (0.62) | L3MBTL3L3MBTL1MBTD1HTR2AHTR2C | |
| Hydrochloric Acid SCHEMBL223935 | 0.84 | HRH3 (0.61) | L3MBTL3L3MBTL1MBTD1KMT2AHRH3 | |
| SCHEMBL7772142 | 0.84 | SLC6A3 (0.61) | L3MBTL3L3MBTL1MBTD1HTR2AHTR2C | |
| Hydrochloric Acid SCHEMBL7447525 | 0.82 | SLC6A3 (0.59) | L3MBTL3L3MBTL1MBTD1HTR2AHTR2C | |
| SCHEMBL27872811 | 0.80 | SPHK1 (0.57) | HTR2AHTR2CHTR7HTR6HRH3 | |
| SCHEMBL27805513 | 0.80 | HRH3 (0.54) | HTR2AHTR2CHTR7HTR6HRH3 | |
| SCHEMBL14320557 | 0.79 | L3MBTL3 (0.67) | L3MBTL3L3MBTL1MBTD1TP53BP1MAPT | |
| SCHEMBL22386773 | 0.77 | LTA4H (0.59) | HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090233910-A1 | Npy antagonists, preparation and uses | CEREP (FR) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233910-A1 | Npy antagonists, preparation and uses | NPY1R, NPY5R, NPY2R | L3MBTL3 4694/4885L3MBTL1 4663/4885MBTD1 3535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.